Talk:Granulocyte colony-stimulating factor
From Wikipedia, the free encyclopedia
A complete merger would seem to taint the information with a commercial bias. Filgrastim is a product that a profit-motivated company is attempting to sell, whereas G-CSF is a chemical produced within the body. Filgrastim should, however, be mentioned under a subheading of the general G-CSF article, with the subheading title "Therapeutic Applications" or some equivalent.
I don't think that the article G-CSF should be merged with filgrastim. In fact, structural description and mechanism of action of (naturally occuring) cytokines should be separated from (genetically engeneered) cytokines produced by drug companies, in order to avoid bias. Same for eg GM-CSF and sagramostim.